Dr. Seungho Lee is the Co-founder and CEO of SUTOL Bio, and a visionary biomedical engineer dedicated to bridging the gap between breakthrough science and clinical reality. As a co-inventor of SUTOL's core gastric-resident technology at MIT's Langer and Traverso Labs, he has spent over six years evolving this academic innovation into a scalable, once-monthly oral platform. With a foundation of 20 patents and 45+ peer-reviewed publications, he is leading SUTOL Bio to redefine treatment adherence and fundamentally improve patient lives globally.
We're advancing the future of drug delivery. Connect with us to explore partnership opportunities.
Contact Our Team